{"id":48144,"date":"2022-09-08T22:02:01","date_gmt":"2022-09-08T20:02:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/"},"modified":"2022-09-08T22:02:01","modified_gmt":"2022-09-08T20:02:01","slug":"tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/","title":{"rendered":"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference"},"content":{"rendered":"
\n

HOUSTON–(BUSINESS WIRE)–#IPF<\/a>–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at 1:30 p.m. ET as well as in one-on-one meetings in New York City on Wednesday, September 14, 2022.\n<\/p>\n

<\/a><\/p>\n

\nAbout Tvardi Therapeutics<\/b>\n<\/p>\n

\nTvardi is a privately held, clinical-stage biopharmaceutical company developing small molecule inhibitors of STAT3, a key regulatory protein positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. STAT3 also plays a central role in the pathogenesis of many inflammatory and fibrotic diseases. The company\u2019s lead product, TTI-101, is completing a first-in-man Phase 1 trial of patients with advanced solid tumors who have failed all lines of therapy. To date, TTI-101 monotherapy has been well-tolerated and has clinical activity across a broad range of tumors including multiple durable radiographic objective responses. The company has now initiated clinical programs in hepatocellular carcinoma, breast cancer, and idiopathic pulmonary fibrosis. To learn more, please visit https:\/\/tvarditherapeutics.com\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTvardi Investor Relations
\n
Sara Manning
\n
ir@tvardi.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at 1:30 p.m. ET as well as in one-on-one meetings in New York City on Wednesday, September … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48144","6":"format-standard","7":"category-industry"},"yoast_head":"\nTvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at 1:30 p.m. ET as well as in one-on-one meetings in New York City on Wednesday, September ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-08T20:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220908005964\/en\/808014\/21\/Tvardi-Master_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference\",\"datePublished\":\"2022-09-08T20:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\"},\"wordCount\":206,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005964\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\",\"name\":\"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005964\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"datePublished\":\"2022-09-08T20:02:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005964\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005964\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend","og_description":"HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at 1:30 p.m. ET as well as in one-on-one meetings in New York City on Wednesday, September ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-08T20:02:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220908005964\/en\/808014\/21\/Tvardi-Master_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference","datePublished":"2022-09-08T20:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/"},"wordCount":206,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005964\/en\/808014\/21\/Tvardi-Master_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/","name":"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005964\/en\/808014\/21\/Tvardi-Master_Logo.jpg","datePublished":"2022-09-08T20:02:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220908005964\/en\/808014\/21\/Tvardi-Master_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220908005964\/en\/808014\/21\/Tvardi-Master_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48144"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48144\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}